Easton Capital — Full Portfolio

Comprehend develops software for clinical trial operations teams to consolidate and analyze trial data from multiple sources in real-time, helping them move treatments through clinical testing more efficiently and safely.

HealthtechSaaSSan Francisco, US

Rick Morrison(Founder/CEO)inPaul Judson Gardner(Executive Officer, Director)Richard V Morrison, Jr.(Executive Officer, Director)Paul Gardner(Executive Officer)Richard V Morrison(Executive Officer, Director)Terence Cunningham(Executive Officer, Director)

Co-investorsLightspeed Venture PartnersY CombinatorCrosslink CapitalSequoia CapitalSV Angel

Developer of drug-eluting stents for coronary artery disease; IPO'd in 2004 and acquired by J&J in 2007.

Co-investorsAPERTURE Venture Partners

Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.

AI & Machine LearningEnterprise SoftwareHealthtechWashington, US

Kevin MacDonald(Executive Officer)Timothy Kress-Spatz(Executive Officer)

Co-investorsKaiser Permanente VenturesLionBirdRex Health VenturesNew Leaf Venture PartnersRock Health

BiotechMalvern, US

Mark Lupher(Executive Officer)Dominick C. Colangelo(Executive Officer, Director)

BoardJames W. Broderick, M.D.(Director)Geert-Jan Mulder(Director)John Friedman(Director)Harold R. Werner(Director)

Co-investorsSofinnova VenturesEaston Capital Investment GroupForbion

Biopharma company developing non-immunosuppressive drugs for autoimmune diseases.

Co-investorsNew Science VenturesWRF Capital

BiotechRedwood City, US

Larry Kauvar(Chief Science Officer)Stefan Ryser(President and Chief Executive Officer)Geoff Dillon(Chief Business Officer)Elisabeth Whitney(Chief Operating Officer)Nora Mende(Chief Financial Officer)

PartnerJohn Friedman· quoted

Co-investorsAMR Action FundNew Science Ventures